Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Frequency Analyses Can Be Improved by a Modified t-test in Sample-based Preclinical Efficacy Studies

Gideon Halperin and Ziv Klausner
PDA Journal of Pharmaceutical Science and Technology January 2013, 67 (1) 74-78; DOI: https://doi.org/10.5731/pdajpst.2013.00903
Gideon Halperin
1Israel Institute for Biological Research, Department of Biotechnology, P.O. Box 19, Ness Ziona, Israel, 74100 and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: halperin@iibr.gov.il
Ziv Klausner
2Israel Institute for Biological Research, Department of Applied Mathematics, P.O. Box 19, Ness Ziona, Israel, 74100
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Sample-based preclinical drug efficacy studies compare frequency (proportion) or incidences of successes within respective samples of test and control groups. The word success in principle refers to a protected (e.g., due to vaccination), recovered, or surviving animal, depending on the particular experiment. We introduce here a modified t-test for two independent groups, aimed at statistical analysis of the difference between frequencies of successes in sample based preclinical studies. The test is applicable whenever the study is based on repeating replicate experiments, as required by certain procedures such as validation. Such experiments are based on constant drug dose and performed under identical conditions and protocol. The proposed test combines the computational rules of t-test for two independent groups and analysis of variance. In the initial steps, incidences are transformed to proportions, and variance between proportions in samples of the jth group (s˜pj2), is then transformed into theoretical weighted variance within the ith repetition (sample) of the jth group (s˜i,j2). The variance of proportions in samples of the size of the whole group (SEj2) is then calculated. The t-statistic is computed according to the rules of t-test for two independent groups. Significance is calculated using (N1 − 1) + (N2 − 1) degrees of freedom, where Nj denotes the total number of animals in the jth group. The proposed model offers an important advantage over incidence or proportion distribution models, such as chi-square or normal approximation of binomial distribution, respectively, because it considers variance between replicate experiments. It moreover offers important flexibility by limiting the requirement for identical sample sizes only to samples within the control or test group. A difference between groups in sample sizes, number of samples, or both, preventing application of block designs or the standard formats of t-test, may still exist. Theoretical considerations and working examples are provided.

LAY ABSTRACT: Sample based preclinical drug efficacy studies compare frequency (proportion) or incidences of successful results (e.g., protected, recovered, or surviving animals, depending on the particular experiment) within respective samples of the test and the control groups. Certain procedures, such as validation, require replicate experiments that are identical in all controllable factors, such as drug dose, sample sizes within each group, general experimental conditions, etc. Still, the control sample size is not required to be identical to that of the respective test sample size. In such cases, t-test or block designs are not applicable for statistical analyses. Moreover, incidence or frequency distribution models, such as chi-square or normal approximation of binomial distribution, respectively, which are performed on pooled data of the examined groups, ignore variance between experiments and thereby result in impaired validity of the statistical inference. We propose here a modified t-test that limits the requirement for identical sample sizes to only within each group. This aim is achieved by combining the computational rules of t-test together with analysis of variance. The proposed t-test allows the incorporating of variance between experiments into frequency or incidence assessments. We recommend using the proposed modified t-test as a complementary test to incidence distribution models.

  • Binomial
  • Chi-square
  • Distribution
  • Drug
  • Efficacy
  • Frequency
  • Preclinical
  • t-test
  • Variance
  • © PDA, Inc. 2013
View Full Text

PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.  

If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing. 

Full issue PDFs are for PDA members only.

Note to pda.org users

The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

Full issue PDFs are for PDA members only. You can join PDA at www.pda.org. 

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 67 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 67, Issue 1
January/February 2013
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Frequency Analyses Can Be Improved by a Modified t-test in Sample-based Preclinical Efficacy Studies
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Frequency Analyses Can Be Improved by a Modified t-test in Sample-based Preclinical Efficacy Studies
Gideon Halperin, Ziv Klausner
PDA Journal of Pharmaceutical Science and Technology Jan 2013, 67 (1) 74-78; DOI: 10.5731/pdajpst.2013.00903

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Frequency Analyses Can Be Improved by a Modified t-test in Sample-based Preclinical Efficacy Studies
Gideon Halperin, Ziv Klausner
PDA Journal of Pharmaceutical Science and Technology Jan 2013, 67 (1) 74-78; DOI: 10.5731/pdajpst.2013.00903
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Theoretical Considerations
    • Operational Example
    • Discussion
    • Conflict of Interest Declaration
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
  • Evaluation of Extreme Depyrogenation Conditions on the Surface Hydrolytic Resistance of Glass Containers for Pharmaceutical Use
  • A Holistic Approach for Filling Volume Variability Evaluation and Control with Statistical Tool
Show more Research

Similar Articles

Keywords

  • Binomial
  • Chi-square
  • Distribution
  • Drug
  • Efficacy
  • Frequency
  • Preclinical
  • t-test
  • Variance

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire